Sepiprod, a production site of Seppic based in Castres, France, has received EXCiPACT certification from MDC Medical Device Certification GmbH, one of EXCiPACT’s internationally-recognized Certification Bodies. Seppic is a subsidiary of Air Luquide.
The site underwent a rigorous assessment process by EXCiPACT auditors to evaluate GMP/GDP compliance for excipients. Sepiprod is the first site in France to be EXCiPACT-registered. Other certified sites include Aug. Hedinder, BASF, and Merck KGaA in Germany.